Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_assertion type Assertion NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_head.
- NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_assertion description "[Our findings underscore the existence of a molecular interplay between LKB1-AMPK-mTORC1 and ErbB2-AKT-mTORC2 pathways with mTOR at its epicenter, suggestive that loss of LKB1 expression may serve as a marker for hyperactivated mTOR in HER2 positive breast cancer and warranting further investigation into therapeutics that target LKB1-AMPK-mTOR and glycolytic pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_provenance.
- NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_assertion evidence source_evidence_literature NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_provenance.
- NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_assertion SIO_000772 23451056 NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_provenance.
- NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_assertion wasDerivedFrom befree-2016 NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_provenance.
- NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_assertion wasGeneratedBy ECO_0000203 NP1056922.RALEYcmzMCQa-QafN6zaLBYnPYSfpuegpXT-kts9MqlDg130_provenance.